⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BBIO News
BridgeBio Pharma, Inc. Common Stock
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BBIO
LYFGENIA (Bluebird bio: lovotibeglogene autotemcel) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
BBIO
Form 8-K
sec.gov
BBIO
Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54
globenewswire.com
BBIO
BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9
globenewswire.com
BBIO
BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions
globenewswire.com
BBIO
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BBIO
Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial Results USA - English APAC - English APAC - Traditional Chinese
prnewswire.com
BBIO
Condor Software Raises $24 Million Series A Funding to Build the First Financial Intelligence Platform for Life Sciences
prnewswire.com
BBIO
MDGL
BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9
globenewswire.com
BBIO